Values as of: 2024-11-16
COMMON STOCK | Specialty Chemicals |
Last Closing
USD 168.64Change
0.00 (0.00)%Market Cap
USD 103.59BVolume
300.00Analyst Target
N/AVerdict
Verdict
L'Air Liquide S.A. provides gases, technologies, and services for the industrial and health sectors in Europe, the Americas, the Asia Pacific, the Middle East, and Africa. It operates in Gas & Services, Engineering & Construction, and Global Markets & Technologies segments. The Gas & Services segment comprises large industries business, which offers gas and energy solutions including oxygen, nitrogen, argon, hydrogen, and carbon monoxide, as well as operates cogeneration plants to supply steam and electricity to metals, chemicals, refining, and energy industries; and industrial merchant business line provides industrial gases, equipment, hardgoods, and associated services to materials and energy, automotive and manufacturing, food and pharmaceuticals, technology and research, and craftsmen and retail sectors. This segment also includes healthcare business, which provides medical gases, home healthcare services, medical equipment, and specialty ingredient to patients, healthcare professionals, and hospitals; and electronic business supply carrier gases, electronic specialty and advanced materials, equipment and installation, and service to semiconductor, flat panel, and photovoltaic markets. The Engineering & Construction segment designs, develops, and builds industrial gas production plants to third parties; and design and manufacture plants in traditional, renewable and alternative energy sectors. The Global Markets & Technologies segment delivers technological solutions, such as molecules, equipment, and services to energy transition and deep technology. This segment also invests in and operates biomethane production units; designs hydrogen refueling stations; and supplies gases for the offshore oil and gas platforms, offshore wind turbines, and cryogenic transportation by sea. L'Air Liquide S.A. was incorporated in 1902 and is headquartered in Paris, France.
Company Website : https://www.airliquide.com
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| AIQUY | Air Liquide SA ADR |
N/A |
USD 103.45B |
| GVDBF | Givaudan SA |
N/A |
USD 48.08B |
| SKFOF | Sika AG |
N/A |
USD 45.12B |
| SXYAY | Sika AG ADR |
N/A |
USD 45.12B |
| GVDNY | Givaudan SA ADR |
N/A |
USD 44.15B |
| DSMFF | DSM-Firmenich AG |
N/A |
USD 32.60B |
| NVZMF | Novozymes A/S B |
N/A |
USD 29.53B |
| NPPHY | Nippon Paint Holdings Co. Ltd. |
N/A |
USD 19.82B |
| EMSHF | EMS-CHEMIE HOLDING AG |
N/A |
USD 18.32B |
| SYIEF | Symrise AG |
N/A |
USD 18.31B |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| TPIF | Timothy Plan Internationa.. | 0.00 % | 0.00 % |
N/A |
USD 0.11B |
| Market Performance vs. Industry/Classification (Specialty Chemicals) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -13.43% | 51% | F | 42% | F | ||
| Dividend Return | 1.79% | 21% | F | 31% | F | ||
| Total Return | -11.65% | 51% | F | 43% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -8.90% | 49% | F | 44% | F | ||
| Dividend Return | 1.88% | 20% | F | 27% | F | ||
| Total Return | -7.03% | 50% | F | 45% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | 27.27% | 84% | B | 73% | C | ||
| Dividend Return | 12.05% | 23% | F | 37% | F | ||
| Total Return | 39.32% | 85% | B | 75% | C | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 8.98% | 54% | F | 52% | F | ||
| Dividend Return | 10.96% | 52% | F | 50% | F | ||
| Total Return | 1.97% | 46% | F | 42% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 19.70% | 86% | B+ | 87% | B+ | ||
| Risk Adjusted Return | 55.63% | 91% | A- | 88% | B+ | ||
| Market Capitalization | 103.59B | 100% | F | 99% | N/A | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers median on a price to book value basis.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company has under performed its peers on annual average total returns in the past 5 years.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
